Literature DB >> 24943657

Titer and product affect the distribution of gene expression after intraputaminal convection-enhanced delivery.

Marina E Emborg1, Samuel A Hurley, Valerie Joers, Do P M Tromp, Christine R Swanson, Sachiko Ohshima-Hosoyama, Viktorya Bondarenko, Kyle Cummisford, Marc Sonnemans, Stephan Hermening, Bas Blits, Andrew L Alexander.   

Abstract

BACKGROUND: The efficacy and safety of intracerebral gene therapy for brain disorders like Parkinson's disease depends on the appropriate distribution of gene expression.
OBJECTIVES: To assess whether the distribution of gene expression is affected by vector titer and protein type.
METHODS: Four adult macaque monkeys seronegative for adeno-associated virus 5 (AAV5) received a 30-µl inoculation of a high- or a low-titer suspension of AAV5 encoding glial cell line-derived neurotrophic factor (GDNF) or green fluorescent protein (GFP) in the right and left ventral postcommissural putamen. The inoculations were conducted using convection-enhanced delivery and intraoperative MRI (IMRI).
RESULTS: IMRI confirmed targeting and infusion cloud irradiation from the catheter tip into the surrounding area. A postmortem analysis 6 weeks after surgery revealed GFP and GDNF expression ipsilateral to the injection site that had a titer-dependent distribution. GFP and GDNF expression was also observed in fibers in the substantia nigra (SN) pars reticulata (pr), demonstrating anterograde transport. Few GFP-positive neurons were present in the SN pars compacta (pc), possibly by direct retrograde transport of the vector. GDNF was present in many neurons of the SNpc and SNpr.
CONCLUSIONS: After controlling for target and infusate volume, the intracerebral distribution of the gene product was affected by the vector titer and product biology.

Entities:  

Mesh:

Year:  2014        PMID: 24943657      PMCID: PMC4127999          DOI: 10.1159/000360584

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  28 in total

1.  Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum.

Authors:  Waldy San Sebastian; R Mark Richardson; Adrian P Kells; Clementine Lamarre; John Bringas; Philip Pivirotto; Ernesto A Salegio; Stephen J Dearmond; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Convection-enhanced delivery.

Authors:  John H Sampson; Raghu Raghavan; Martin Brady; Allan H Friedman; Darell Bigner
Journal:  J Neurosurg       Date:  2011-05-27       Impact factor: 5.115

Review 3.  Diffusion of macromolecules in the brain: implications for drug delivery.

Authors:  Daniel J Wolak; Robert G Thorne
Journal:  Mol Pharm       Date:  2013-01-31       Impact factor: 4.939

4.  Risk of surgical delivery to deep nuclei: a meta-analysis.

Authors:  Jonathan Kimmelman; Katherine Duckworth; Tim Ramsay; Tiffini Voss; Bernard Ravina; Marina Elena Emborg
Journal:  Mov Disord       Date:  2011-05-14       Impact factor: 10.338

5.  Intraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primates.

Authors:  Marina E Emborg; Valerie Joers; Ronald Fisher; Kevin Brunner; Victoria Carter; Chris Ross; Raghu Raghavan; Martin Brady; James Raschke; Ken Kubota; Andrew Alexander
Journal:  Cell Transplant       Date:  2010-06-29       Impact factor: 4.064

6.  Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain.

Authors:  Nikisha Carty; Daniel Lee; Chad Dickey; Carolina Ceballos-Diaz; Karen Jansen-West; Todd E Golde; Marcia N Gordon; Dave Morgan; Kevin Nash
Journal:  J Neurosci Methods       Date:  2010-10-15       Impact factor: 2.390

7.  Pathways of infusate loss during convection-enhanced delivery into the putamen nucleus.

Authors:  Martin L Brady; Raghu Raghavan; Andrew Alexander; Ken Kubota; Karl Sillay; Marina E Emborg
Journal:  Stereotact Funct Neurosurg       Date:  2013-01-22       Impact factor: 1.875

8.  Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.

Authors:  Carmen Unzu; Sandra Hervás-Stubbs; Ana Sampedro; Itsaso Mauleón; Uxua Mancheño; Carlos Alfaro; Rafael Enríquez de Salamanca; Alberto Benito; Stuart G Beattie; Harald Petry; Jesús Prieto; Ignacio Melero; Antonio Fontanellas
Journal:  J Transl Med       Date:  2012-06-15       Impact factor: 5.531

9.  A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys.

Authors:  Sachiko Ohshima-Hosoyama; Heather A Simmons; Nichole Goecks; Valerie Joers; Christine R Swanson; Viktoriya Bondarenko; Rebecca Velotta; Kevin Brunner; Laura D Wood; Ralph H Hruban; Marina E Emborg
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

10.  The MRI contrast agent gadoteridol enhances distribution of rAAV1 in the rat hippocampus.

Authors:  R Hullinger; J Ugalde; L Purón-Sierra; S Osting; C Burger
Journal:  Gene Ther       Date:  2013-09-19       Impact factor: 5.250

View more
  8 in total

1.  Real-Time Intraoperative MRI Intracerebral Delivery of Induced Pluripotent Stem Cell-Derived Neurons.

Authors:  Scott C Vermilyea; Jianfeng Lu; Miles Olsen; Scott Guthrie; Yunlong Tao; Eva M Fekete; Marissa K Riedel; Kevin Brunner; Carissa Boettcher; Viktorya Bondarenko; Ethan Brodsky; Walter F Block; Andrew Alexander; Su-Chun Zhang; Marina E Emborg
Journal:  Cell Transplant       Date:  2016-09-14       Impact factor: 4.064

2.  Overexpressing Corticotropin-Releasing Factor in the Primate Amygdala Increases Anxious Temperament and Alters Its Neural Circuit.

Authors:  Ned H Kalin; Andrew S Fox; Rothem Kovner; Marissa K Riedel; Eva M Fekete; Patrick H Roseboom; Do P M Tromp; Benjamin P Grabow; Miles E Olsen; Ethan K Brodsky; Daniel R McFarlin; Andrew L Alexander; Marina E Emborg; Walter F Block; Julie L Fudge; Jonathan A Oler
Journal:  Biol Psychiatry       Date:  2016-01-30       Impact factor: 13.382

3.  Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders.

Authors:  Patrick H Roseboom; Sascha A L Mueller; Jonathan A Oler; Andrew S Fox; Marissa K Riedel; Victoria R Elam; Miles E Olsen; Juan L Gomez; Matthew A Boehm; Alexandra H DiFilippo; Bradley T Christian; Michael Michaelides; Ned H Kalin
Journal:  Mol Ther       Date:  2021-04-23       Impact factor: 11.454

Review 4.  Neuroprotective Surgical Strategies in Parkinson's Disease: Role of Preclinical Data.

Authors:  Napoleon Torres; Jenny Molet; Cecile Moro; John Mitrofanis; Alim Louis Benabid
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

5.  MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain.

Authors:  L Samaranch; B Blits; W San Sebastian; P Hadaczek; J Bringas; V Sudhakar; M Macayan; P J Pivirotto; H Petry; K S Bankiewicz
Journal:  Gene Ther       Date:  2017-03-16       Impact factor: 5.250

Review 6.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

7.  Functional Intercellular Transmission of miHTT via Extracellular Vesicles: An In Vitro Proof-of-Mechanism Study.

Authors:  Roberto D V S Morais; Marina Sogorb-González; Citlali Bar; Nikki C Timmer; M Leontien Van der Bent; Morgane Wartel; Astrid Vallès
Journal:  Cells       Date:  2022-09-03       Impact factor: 7.666

Review 8.  Gene Therapy for Parkinson's Disease, An Update.

Authors:  Tobias M Axelsen; David P D Woldbye
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.